Outline
MISSION
Providing a next-generation platform for genomic medicine.
Company Profile

We specialize in the development, manufacturing, and sales of raw materials for clinical diagnostics and medical device systems. In particular, our proprietary technology enables the capture and separation of glycan structures specific to cancer-derived substances, contributing to the enhanced precision of liquid biopsy.
This innovation allows for simple and non-invasive testing using saliva or blood, with the potential to support early cancer detection.
At The IT Lab, we are committed to building the next-generation healthcare platform. We are actively engaged in the field of genomic medicine, aiming to deliver personalized treatments tailored to each individual patient.
Company Profile
Company Name | The IT Lab Co., Ltd. |
Founded | April 19, 2022 |
Board Member | CEO Yoshihiro Taguchi Director/CTO Tadataka Kamiyama |
Technical Advisor | Kanji Hori (Professor Emeritus, Hiroshima University) Hiroshi Kurokawa |
Capital | JPY 25.3 million |
Head Office | 2-4-23 Kita-Iioka, Morioka-shi,Iwate 020-0857, Japan |
Phone | +81-19-909-0251 |
y.taguchi@the-itlab.com |